Literature DB >> 1973594

Risk factors for progression of human immunodeficiency virus (HIV) infection among seroconverted and seropositive homosexual men.

G J van Griensven1, E M de Vroome, F de Wolf, J Goudsmit, M Roos, R A Coutinho.   

Abstract

For identification of risk factors for progression of human immunodeficiency virus (HIV) infection, 746 homosexual men participating in a cohort study in Amsterdam, The Netherlands, were studied since October 1984. A total of 234 of these men were HIV antibody-positive at baseline, and 52 seroconverted during follow-up. These 286 individuals were categorized as high- and low-risk for progression to the acquired immunodeficiency syndrome (AIDS) on the basis of the presence or absence of HIV antigenemia, antibody to HIV core antigen, or a number of T helper lymphocytes less than 0.5 x 10(9)/liter during three or more subsequential blood samples. Ninety-six (41%) of the seropositives and 32 (62%) of those who seroconverted remained low-risk throughout the study period. Bivariate analyses revealed that educational level and a history of herpes zoster were associated with a low- and high-risk status, respectively. In multivariate analyses, a history of herpes zoster and a history of sexual intercourse with a person who had AIDS were associated with a more rapid disease progression. While herpes zoster is considered to be a marker of progressive immunodeficiency, a history of having sexual intercourse with a person who had AIDS points to the more virulent properties of HIV in these persons. Because both seropositives and seroconverters who had sexual intercourse with a person with AIDS had a more rapid disease progression, it seems plausible that being infected by a person with AIDS is a risk factor for a relative short incubation period.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1973594     DOI: 10.1093/oxfordjournals.aje.a115649

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  6 in total

1.  Herpes zoster and the stage and prognosis of HIV-1 infection.

Authors:  A McNulty; Y Li; U Radtke; J Kaldor; R Rohrsheim; D A Cooper; B Donovan
Journal:  Genitourin Med       Date:  1997-12

Review 2.  Adding fuel to the fire: alcohol's effect on the HIV epidemic in Sub-Saharan Africa.

Authors:  Judith A Hahn; Sarah E Woolf-King; Winnie Muyindike
Journal:  Curr HIV/AIDS Rep       Date:  2011-09       Impact factor: 5.071

3.  Clinical utility of an enhanced human immunodeficiency virus type 1 p24 antigen capture assay.

Authors:  M B Vasudevachari; N P Salzman; D R Woll; C Mast; K W Uffelman; G Toedter; D Hoefheinz; J A Metcalf; H C Lane
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

Review 4.  Alcohol and HIV disease progression: weighing the evidence.

Authors:  Judith A Hahn; Jeffrey H Samet
Journal:  Curr HIV/AIDS Rep       Date:  2010-11       Impact factor: 5.071

Review 5.  Chronic alcohol abuse and HIV disease progression: studies with the non-human primate model.

Authors:  Angela M Amedee; Whitney A Nichols; Spencer Robichaux; Gregory J Bagby; Steve Nelson
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

6.  Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo.

Authors:  R Shibata; M D Hoggan; C Broscius; G Englund; T S Theodore; A Buckler-White; L O Arthur; Z Israel; A Schultz; H C Lane
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.